AbbVie Reports Second-Quarter 2024 Financial Results | AbbVie

AbbVie Reports Second-Quarter 2024 Financial Results | AbbVie

1 week from now

Jul 25, 2024  · Reports Second-Quarter Diluted EPS of $0.77 on a GAAP Basis, a Decrease of 32.5 Percent; Adjusted Diluted EPS of $2.65, a Decrease of 8.9 Percent; These Results …

abbvie.com

AbbVie’s Q2 2024 Net Earnings Drop To $1.37bn - Yahoo Finance

1 week from now

Jul 26, 2024  · AbbVie has announced its financial results for the second quarter (Q2) of 2024, revealing a 32.1% decrease in net earnings attributable to the company of $1.37bn from …

yahoo.com

AbbVie Second Quarter 2024 Earnings: Revenues Beat …

1 week from now

Jul 27, 2024  · AbbVie ( NYSE:ABBV ) Second Quarter 2024 Results Key Financial Results Revenue: US$14.5b (up 4.3% from 2Q 2023). Net...

yahoo.com

AbbVie (ABBV) Q2 2024 Earnings Call Transcript - Nasdaq

1 week from now

Jul 25, 2024  · Scott Reents-- Executive Vice President, Chief Financial Officer. Starting with our second quarter results. We reported adjusted earnings per share of $2.65, which is $0.10 …

nasdaq.com

AbbVie Reports First-Quarter 2024 Financial Results

1 week from now

Apr 26, 2024  · Reports First-Quarter Diluted EPS of $0.77 on a GAAP Basis, an Increase of 492.3 Percent; Adjusted Diluted EPS of $2.31, a Decrease of 6.1 Percent; These Results Include an …

abbvie.com

Cybin Initiates PARADIGM: A Multinational Pivotal Phase 3 …

1 week from now

5 days ago  · Net loss was C$57.2 million for the quarter ended September 30, 2024, which includes a non-recurring, non-cash component related to share-based compensation, …

businesswire.com

AbbVie Reports Second-Quarter 2024 Financial Results - PR …

1 week from now

Jul 25, 2024  · AbbVie is raising its adjusted diluted EPS guidance for the full year 2024 from $10.61 - $10.81 to $10.71 - $10.91, which includes an unfavorable impact of $0.60 per share …

prnewswire.com

Financial Releases - AbbVie

1 week from now

Dec 6, 2023  · AbbVie Reports First-Quarter 2024 Financial Results Reports First-Quarter Diluted EPS of $0.77 on a GAAP Basis, an Increase of 492.3 Percent; Adjusted Diluted EPS of $2.31 , …

abbvie.com

Cybin - Cybin Initiates PARADIGM: A Multinational Pivotal Phase 3 ...

1 week from now

5 days ago  · Second Quarter Fiscal Year 2025 Financial Information Cash totaled C$154.3 million as of September 30, 2024. With the completion of offerings and a combination of the …

cybin.com

ABVC BioPharma, Inc. Reports Q3 2024 Financial Results And

1 week from now

Sep 30, 2024  · ABVC BioPharma Achieved its First Operational Profit, with a 102% Improvement over the Third Quarter of Last Year. Incremental Payments Received based on Executed …

nasdaq.com

2024-11-13 | Roadzen Reports Fiscal Second Quarter And First Half ...

1 week from now

5 days ago  · Second Quarter and First Half Financial Highlights: Revenue and Key Performance Indicators. Revenue for the second quarter totaled $11.9 million, an increase of 33% over the …

stockhouse.com

Gladstone Investment Corporation Reports Financial Results For Its ...

1 week from now

Nov 7, 2024  · Second Quarter Results: Net investment income for the quarter ended September 30, 2024 was $7.3 million, or $0.20 per weighted-average common share, compared to net …

accesswire.com

AbbVie Reports Third-Quarter 2024 Financial Results | AbbVie

1 week from now

Oct 30, 2024  · Reports Third-Quarter Diluted EPS of $0.88 on a GAAP Basis, a Decrease of 12.0 Percent; Adjusted Diluted EPS of $3.00, an Increase of 1.7 Percent; These Results Include an …

abbvie.com

AbbVie Reports Second-Quarter 2024 Financial Results

1 week from now

Jul 25, 2024  · AbbVie is raising its adjusted diluted EPS guidance for the full year 2024 from $10.61 - $10.81 to $10.71 - $10.91, which includes an unfavorable impact of $0.60 per share …

stocktitan.net

Altimmune Announces Third Quarter 2024 Financial Results And …

1 week from now

Sep 30, 2024  · Financial Results for the Three Months Ended September 30, 2024: Altimmune had cash, cash equivalents and short-term investments totaling $139.4 million on September …

altimmune.com

AbbVie Reports Second-Quarter 2024 Financial Results

1 week from now

Jul 26, 2024  · — Raises 2024 Adjusted Diluted EPS Guidance Range from $10.61 – $10.81 to $10.71 – $10.91, which Includes an Unfavorable Impact of $0.60 Per Share Related to …

comtex.com